About
Approach
Investment Model
Investment Scope
Our approach
Team
Managing Partner
Partners
Our team
Portfolio
News
Connect
Pages
Pages
Home
About
Blog
Blog Post
Contact
Portfolio
Investors
Investor Single
Shop
Shop Single
Utility Pages
Start Here
Style Guide
404 Not Found
Password Protected
Licenses
Changelog
Browse More Templates
Chime Biologics Announces Strategic Collaboration with Beijing Libang Pharmaceutical on Global Blinatumomab Biosimilar Program
Article Date
December 10, 2025
This article is featured on another website.
Go to article
Related posts
Browse all articles
March 26, 2026
pharmaphorum – BIO‑Europe Spring 2026: In conversation with Marjorie Sidhoum, Vice President of Business Development and Corporate Communications at Kainova Therapeutics
March 26, 2026
pharmaphorum – BIO‑Europe Spring 2026: In conversation with Marjorie Sidhoum, Vice President of Business Development and Corporate Communications at Kainova Therapeutics
May 1, 2026
Headed to ASCO 2026? Meet the HiRO Team in Chicago
HiRO will be Attending the ASCO Annual Meeting: Advancing Oncology Innovation | Visit Us at…
May 1, 2026
Headed to ASCO 2026? Meet the HiRO Team in Chicago
HiRO will be Attending the ASCO Annual Meeting: Advancing Oncology Innovation | Visit Us at…